作者: Jeff Sperinde , Gundo Diedrich , Gordon Parry , Laurie Goodman , Michael Bates
DOI:
关键词: Patient response 、 Internal medicine 、 Clinical trial 、 Cancer treatment 、 Time to progression 、 Medicine 、 Treatment regimen 、 Biomarker (medicine) 、 Oncology 、 Surgery
摘要: Methods are provided for determining or otherwise assessing the response of a patient to treatment, in particular, cancer treatment. The methods include analysis samples presence absence HER2 markers alone conjunction with other biomarkers, such as HER3 markers. In certain examples, probable time progression can be determined by first positive patients and then further stratifying using second biomarker (e.g, markers). addition, data used track patient's treatment regimen, expected success treating particular regiment, effects regiment categorizing order create homogenous group clinical trial.